Company Overview and News
NEW YORK – The Hellenic Initiative (THI), which leads the Greek diaspora community internationally in raising awareness and capital for Greece, is hosting its 6th Annual Gala on Friday, September 21 at the New York Hilton, 1335 Avenue of the Americas in Midtown Manhattan, to raise funds that will be invested in entrepreneurial programs in Greece. The black tie gala also will support Greek NGOs that foster economic development opportunities and provide crisis relief for underserved communities in Greece, particularly children.
2018-09-17 cnbc - 1
DowDupont – CEO Edward Breen will become executive chairman of the specialty products company resulting from DowDupont's planned split into three companies next year. That unit will take the DuPont name. It had been previously announced that current DowDupont executive Jim Fitterling will become CEO of Dow Chemical, the name DowDupont will take when the other two companies – to be known as DuPont and Corteva Agriscience – are separated.
WFC WFCNP MDP MDPEB DOW
DowDuPont Inc.’s (DWDP - Free Report) subsidiary — The Dow Chemical Company — announced high return, low-capital intensity investments in its downstream and upstream silicones franchise. The move is expected to accelerate innovation and support global demand in high growth markets including consumer goods, electrical and industrial, home and personal care as well as high performance building. The investment plan includes a new hydroxyl functional siloxane polymer facility in Carrollton, KY.
CY DOW NGVT DWDP NGVT.WI CE
LAFAYETTE, Ind., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Wabash National Corporation (NYSE: WNC) recognized top suppliers today during its annual Supplier Conference. More than 300 attendees representing 240 companies attended the conference in Lafayette, Indiana, during which 29 suppliers received awards for exceptional performance.
Our next presenter is the one you've all been waiting for. Jim Fitterling will be the next CEO of Dow Chemical, the Materials Science fin of DowDuPont. With him as always is Neal Sheorey, lead IR, who I've had the pleasure of dealing with several years, and Neal, thanks again for the commitment for taking your team here.
BLOOMFIELD HILLS, Mich., Sept. 12, 2018 (GLOBE NEWSWIRE) -- TriMas (NASDAQ: TRS) today announced that its Rieke business has been named by The Dow Chemical Company as a Diamond Finalist during the 2018 30th Awards for Packaging Innovation.
DUBAI (Reuters) - Saudi Arabia’s sovereign wealth fund has chosen Goldman Sachs, Bank of America Merrill Lynch and Michael Klein as advisers on its planned sale of a stake in petrochemicals firm SABIC to Saudi Aramco, sources familiar with the process said.
C CGBBW DOW MS
2018-09-07 investorplace - 2
In a market near all-time highs, chemical stocks look like a potential source of value. Shares of top chemical companies still look reasonably cheap, with many priced at a mid-teen — or lower — multiples to earnings and free cash flow.
SEE ALB GRA LYB DWDP FUL LALWF DOW TSLA SQM TROX MMM
Good afternoon ladies and gentlemen. Welcome to Workday's Second Quarter Fiscal Year 2019 earnings call. At this time, all participants are in listen-only mode. We will conduct a question-and-answer session towards the end of the call.
WDAY DOW MS
Each year, Peter Drucker’s Drucker Institute generates its Management Top 250, evaluating companies based on five dimensions of corporate performance. Those five dimensions are Customer Satisfaction, Employee Engagement and Development, Innovation, Social Responsibility and Financial Strength.
DOW OC GM EW
2018-09-03 seekingalpha - 1
Glenview Capital Management's 13F portfolio value decreased from $17.10B to $14.66B this quarter. The number of positions decreased from 52 to 49.
LOW ATHTF FLEX LBTY WBA ENL CVS HPE SHPG NWL LBTYK LILAB WMB DOW MTOR CAH DXC AET CMCSK IQV EBAY MIK TMUSP TMUS BKD CBS.WD VER CNDT GOOGL LILAK RLGY MSFT CPV MHK ENDP FB PAH TMO CCV MCK CCZ GOOG DLPH CHTR AGN DXC.WI CI ARMK HOLX CBS CSC CBS.A CMCSA FTI.WI FMC LBTYB LBTYA FDX ANTM HUM DWDP ABC V CCV.CL FDC THC APTV ANTX LILA
Liveris will work closely with the Public Investment Fund (PIF) on matters of strategic importance, assist the fund in efforts to boost the value of its portfolio, and ensure the contribution of PIF companies to Saudi Arabia's economic vision program 2030, the fund said in a statement on Sunday..
DUBAI, UNITED ARAB EMIRATES – In its highest-profile appointment of any global manufacturing executive, Saudi Arabia’s sovereign fund has named Andrew Liveris, the former chairman and chief executive of Dow Chemical, as a special adviser.
DOW 9984 SFTBF SFTBY
DUBAI (Reuters) - Saudi Arabia’s sovereign fund has appointed Andrew Liveris, the former chairman and chief executive of Dow Chemical, as a special adviser, it said on Sunday.
Here is the speech Benjamin Graham gave in San Francisco one week before John F. Kennedy was assassinated. In this brilliant presentation, Graham explores how an investor should go about determining whether the market is overvalued, how to tell which asset allocation is right for you, and how to pick stocks wisely. This speech is a rare opportunity to see the workings of Graham’s mind in the raw.
IBM GEC GE DOW DTK GNE
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to DOW / Dow Chemical Co. (The) on message board site Silicon Investor.
as of ET